Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Surpass EstimatesPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Surpass Estimates

BioMarin Pharmaceutical (BMRN) came out with quarterly earnings of $1.44 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $0.96 per share a year ago

Castle Biosciences, Inc. (CSTL) Q2 Earnings and Revenues Surpass Estimates
Castle Biosciences, Inc. (CSTL) Q2 Earnings and Revenues Surpass Estimates

Castle Biosciences, Inc. (CSTL) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of a loss of $0.51 per share. This compares to earnings of $0.31 per share a

CVRx (CVRX) Reports Q2 Loss, Beats Revenue Estimates
CVRx (CVRX) Reports Q2 Loss, Beats Revenue Estimates

CVRx (CVRX) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to a loss of $0.65 per share a year ago. These figures are

Simon Property (SPG) Q2 FFO Beat Estimates
Simon Property (SPG) Q2 FFO Beat Estimates

Simon Property (SPG) came out with quarterly funds from operations (FFO) of $3.05 per share, beating the Zacks Consensus Estimate of $3.04 per share. This compares to FFO of $2.9 per share a year

Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Beats Revenue EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Beats Revenue Estimates

Syndax Pharmaceuticals (SNDX) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Estimate of a loss of $1. This compares to a loss of $0.8 per share a year ago. These

Vitesse Energy (VTS) Surpasses Q2 Earnings and Revenue Estimates
Vitesse Energy (VTS) Surpasses Q2 Earnings and Revenue Estimates

Vitesse Energy (VTS) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.35 per share a year ago. These

Vertex Pharmaceuticals (VRTX) Surpasses Q2 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Vertex Pharmaceuticals (VRTX) Surpasses Q2 Earnings and Revenue Estimates

Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of $4.52 per share, beating the Zacks Consensus Estimate of $4.24 per share. This compares to a loss of $12.83 per share a year ago

Diamondback Energy (FANG) Tops Q2 Earnings and Revenue Estimates
Diamondback Energy (FANG) Tops Q2 Earnings and Revenue Estimates

Diamondback Energy (FANG) came out with quarterly earnings of $2.67 per share, beating the Zacks Consensus Estimate of $2.63 per share. This compares to earnings of $4.52 per share a year ago. These

Heidrick & Struggles (HSII) Q2 Earnings and Revenues Beat Estimates
Heidrick & Struggles (HSII) Q2 Earnings and Revenues Beat Estimates

Heidrick & Struggles (HSII) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.67 per share a year ago

SBA Communications (SBAC) Q2 FFO and Revenues Surpass Estimates
SBA Communications (SBAC) Q2 FFO and Revenues Surpass Estimates

SBA Communications (SBAC) came out with quarterly funds from operations (FFO) of $3.17 per share, beating the Zacks Consensus Estimate of $3.12 per share. This compares to FFO of $3.29 per share a

Axon Enterprise (AXON) Tops Q2 Earnings and Revenue Estimates
Axon Enterprise (AXON) Tops Q2 Earnings and Revenue Estimates

Axon Enterprise (AXON) came out with quarterly earnings of $2.12 per share, beating the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $1.2 per share a year ago. These

Lattice Semiconductor (LSCC) Matches Q2 Earnings EstimatesPhoto, wide shot, wide-angle lens,  Artificial intelligence developer, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/ee32e77c-b7d6-424b-91ea-4023f2292688.png
Lattice Semiconductor (LSCC) Matches Q2 Earnings Estimates

Lattice Semiconductor (LSCC) came out with quarterly earnings of $0.24 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.23 per share a year ago. These figures

Dorman Products (DORM) Q2 Earnings and Revenues Beat Estimates
Dorman Products (DORM) Q2 Earnings and Revenues Beat Estimates

Dorman Products (DORM) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $1.76 per share. This compares to earnings of $1.67 per share a year ago. These

Allegiant Travel (ALGT) Q2 Earnings Beat EstimatesPhoto, wide shot, wide-angle lens,  Online marketplace, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/27d484d8-d1b1-4519-9797-b5dcaa68d4e2.png
Allegiant Travel (ALGT) Q2 Earnings Beat Estimates

Allegiant Travel (ALGT) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $1.77 per share a year ago. These

Is Opendoor Technologies the Next Carvana?
Is Opendoor Technologies the Next Carvana?

Is Opendoor About to Have Its ‘Carvana Moment’?

Opendoor Technologies Company Overview

Founded a little more than a decade ago in San Francisco, California, Zacks Rank #3 (Hold) stock Opendoor

Top Stock Picks for Week of August 4, 2025Photo, wide shot, wide-angle lens,  Metal fabrication, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.midjourneyapi.xyz/temp/138548fd-aba2-4b3e-b9ee-93725b372952.png
Top Stock Picks for Week of August 4, 2025

GE Aerospace (GE) (erstwhile General Electric Company) is a leading designer, developer and producer of jet engines, components and integrated systems for military, commercial and business aircraft

Buy AMD Stock for New Peaks as Q2 Earnings Approach?Photo, wide shot, wide-angle lens,  Consumer electronics manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://img.theapi.app/temp/d8a4268f-c982-4aa8-a09e-f9ee1db62f57.png
Buy AMD Stock for New Peaks as Q2 Earnings Approach?

AMD AMD will be a highlight of this week’s earnings lineup, with the chip leader set to release its Q2 report after-market hours on Tuesday, August 5.

Like Nvidia NVDA, which is scheduled to report

Exxon (XOM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Exxon (XOM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2025, Exxon Mobil (XOM) reported revenue of $81.51 billion, down 12.4% over the same period last year. EPS came in at $1.64, compared to $2.14 in the year-ago quarter.

The

Do Options Traders Know Something About Royal Gold Stock We Don't?: https://pixabay.com/de/photos/gold-ingots-golden-schatz-513062/
Do Options Traders Know Something About Royal Gold Stock We Don't?

Investors in Royal Gold, Inc. RGLD need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 19, 2025 $70 Call had some of the highest implied

Is the Options Market Predicting a Spike in Birkenstock Holding Stock?
Is the Options Market Predicting a Spike in Birkenstock Holding Stock?

Investors in Birkenstock Holding plc BIRK need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 17, 2025 $22.5 Call had some of the highest

Top Research Reports for NextEra Energy, Applied Materials & Petrobras
Top Research Reports for NextEra Energy, Applied Materials & Petrobras

Monday, August 4, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NextEra

Should You Buy, Hold, Or Sell QUBT Stock Ahead of Q2 Earnings?
Should You Buy, Hold, Or Sell QUBT Stock Ahead of Q2 Earnings?

Quantum Computing Inc. QUBT is expected to report second-quarter 2025 results shortly.

The Zacks Consensus Estimate for second-quarter revenues is currently pegged at 0.10 million, projecting a

Watch These 3 "Mag 7" Stocks Showing Positive Momentum
Watch These 3 "Mag 7" Stocks Showing Positive Momentum

Richard Driehaus has secured a spot in Barron’s All-Century Team thanks to a strategy based on the "buy high and sell higher" theory. This approach is undeniably effective for selecting top momentum

NVIDIA & 2 Other Profitable Stocks to Retain in AugustPhoto, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/012f8213-0bd1-4831-98f2-6d5fae956d6a.png
NVIDIA & 2 Other Profitable Stocks to Retain in August

Investors should look for companies that generate strong returns after accounting for all operating and non-operating expenses. Therefore, it’s wise to invest in a profitable company rather than one

Viatris Poised to Report Q2 Earnings: What's in Store for the Stock?Photo, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Viatris Poised to Report Q2 Earnings: What's in Store for the Stock?

Viatris (VTRS), a global healthcare company, is scheduled to report second-quarter 2025 results on Aug. 7, 2025, before the bell.

The Zacks Consensus Estimate for revenues is pegged at $3.50